Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
We announce a new Special Series of articles devoted to advanced medicine.
Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.
A new computational tool could help improve the stability and predictability of ADCs.
Jane Osbourn talks about the potential of the UK's cell and gene therapy space.
"Moving beyond Cas9 may be the secret to reducing CRISPR’s off-target effects," says Garrett Rettig.
Can new tools lower the hurdle of high manufacturing costs for cell and gene therapies?
After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.
Philip W. Wills
Now that Gene therapy's promise has been shown, the industry must focus on improving the manufacturing process and bring down costs.
Glad tidings of progress and confidence this (conference) season! But let’s not dismiss the emerging skills challenge as “humbug.”
The UK’s CGT Catapult has played a significant role in building the strong advanced therapy ecosystem in the UK, the largest outside the USA.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.